Large consortium, including Euretos, focuses on understanding the metabolic factors determining COVID-19 disease progression for personalised interventions
Which genes associated with early onset Alzheimer’s disease have been involved in a clinical trial or study?
Major consortium, combines Euretos AI Platform with real world and clinical observations to create and validate Covid-19 disease model
Researchers use Euretos platform to identify molecular mechanisms underlying key comorbidities
Euretos co-founds lab addressing Covid-19 as a first use case
Euretos joins multiple COVID-19 consortia
Euretos presenting at the Innovation for Health conference
Lancet publication mentions Euretos in drug repurposing for Autosomal Dominant Polycystic Kidney Disease
Enabling the transformation to data driven disease and drug research
Subscribe to our quarterly market update
© 2020 Euretos.
T&Cs - Services
T&Cs - AI Platform